<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04691674</url>
  </required_header>
  <id_info>
    <org_study_id>2020-10-024-003</org_study_id>
    <nct_id>NCT04691674</nct_id>
  </id_info>
  <brief_title>Optimal Placement Duration of Pancreatic Duct Stent</brief_title>
  <official_title>Optimal Placement Duration of Pancreatic Duct Stent Inserted During ERCP: 2 vs 4 Weeks</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DongGuk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gachon University Gil Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gyeongsang National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kyungpook National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Catholic University of Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Korea University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pusan National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>DongGuk University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized controlled trial to determine the optimal placement duration of pancreatic duct&#xD;
      stents (PDS) inserted during ERCP: 2 vs 4 weeks&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Endoscopic pancreatic duct stenting has been increasingly used for the treatment of a variety&#xD;
      of pancreatic disorders including chronic pancreatitis, pancreatic duct stricture, drainage&#xD;
      of pseudocysts, and the prevention of pancreatitis following endoscopic retrograde&#xD;
      cholangiopancreatography (ERCP). Several randomized, controlled trials and meta-analyses have&#xD;
      proven a significant reduction in incidence and severity of post-ERCP pancreatitis (PEP) with&#xD;
      prophylactic pancreatic duct stenting. The US and European guidelines recommend that&#xD;
      pancreatic duct stents (PDS) be placed between 7-10 days and 5-10 days, respectively, in&#xD;
      order to prevent PEP in some situations. Therefore, the placement of PDS has been an&#xD;
      established essential procedure for preventing a fatal complication, PEP. Furthermore, PDS&#xD;
      placement can facilitate difficult common bile duct cannulation. It may help not only to&#xD;
      straighten papillary anatomy but also to identify the location of the biliary orifice.&#xD;
&#xD;
      However, PDS tends to become occluded easily due to protein content, calcium carbonate&#xD;
      crystals, and bacteria in the pancreatic juice. The occluded PDS can cause acute pancreatitis&#xD;
      or abdominal pain. For this reason, the guidelines recommend PDS be placed within 10 days.&#xD;
      Because of this policy, the patient must take the inconvenience of undergoing another&#xD;
      endoscopic procedure to remove the PDS. However, all patients with occluded PDS do not have&#xD;
      symptoms such as pain. In one series, only 6 percent of patients with clogged PDS developed&#xD;
      symptoms. The low incidence of symptoms despite a high rate of stent occlusion suggests that&#xD;
      the stent may function as a wick around which pancreatic juices continue to drain. In&#xD;
      addition, the rate of spontaneous stent dislodgement was relatively high (65-86%) within 30&#xD;
      days according to a previous study. A recent study also reported that prolonged retention of&#xD;
      prophylactic pancreatic stents is not associated with increased complications.&#xD;
&#xD;
      Taken together, PDS placed during ERCP do not need to be removed until any symptom develops.&#xD;
      In particular, if the investigators can observe PDS for about a month without removing them,&#xD;
      the PDS are more likely to pass out spontaneously, which could reduce unnecessary procedures.&#xD;
      However, to date, there have been few randomized controlled studies on the optimal placement&#xD;
      duration of PDS inserted during ERCP.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with undergoing endoscopic procedures</measure>
    <time_frame>2 weeks (control group) or 4 weeks (study group) following ERCP</time_frame>
    <description>The necessity of endoscopic procedure for pancreatic duct stent removal</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Cholangitis</condition>
  <condition>Post-ERCP Acute Pancreatitis</condition>
  <condition>Stent Dislodgement</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endoscopic removal of pancreatic duct stent at 4 weeks following ERCP, unless spontaneously dislodged.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Endoscopic removal of pancreatic duct stent at 2 weeks following ERCP, unless spontaneously dislodged.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopy</intervention_name>
    <description>Endoscopic removal of the pancreatic stent</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Study group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who underwent the pancreatic duct stent placement during ERCP&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who had pancreatic duct stent for the purpose of pancreatic interventions&#xD;
&#xD;
          -  Patients who underwent simultaneous bile duct stenting&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dong Kee Jang, MD, PhD</last_name>
    <phone>+82319617129</phone>
    <email>mapmotive@hanmail.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dongguk University Ilsan Hospital</name>
      <address>
        <city>Goyang-si</city>
        <state>Gyeonggi-do</state>
        <zip>10326</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <results_reference>
    <citation>Mazaki T, Mado K, Masuda H, Shiono M. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis. J Gastroenterol. 2014 Feb;49(2):343-55. doi: 10.1007/s00535-013-0806-1. Epub 2013 Apr 24. Review.</citation>
    <PMID>23612857</PMID>
  </results_reference>
  <results_reference>
    <citation>Choudhary A, Bechtold ML, Arif M, Szary NM, Puli SR, Othman MO, Pais WP, Antillon MR, Roy PK. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc. 2011 Feb;73(2):275-82. doi: 10.1016/j.gie.2010.10.039. Review.</citation>
    <PMID>21295641</PMID>
  </results_reference>
  <results_reference>
    <citation>ASGE Standards of Practice Committee, Chandrasekhara V, Khashab MA, Muthusamy VR, Acosta RD, Agrawal D, Bruining DH, Eloubeidi MA, Fanelli RD, Faulx AL, Gurudu SR, Kothari S, Lightdale JR, Qumseya BJ, Shaukat A, Wang A, Wani SB, Yang J, DeWitt JM. Adverse events associated with ERCP. Gastrointest Endosc. 2017 Jan;85(1):32-47. doi: 10.1016/j.gie.2016.06.051. Epub 2016 Aug 18. Review.</citation>
    <PMID>27546389</PMID>
  </results_reference>
  <results_reference>
    <citation>Dumonceau JM, Kapral C, Aabakken L, Papanikolaou IS, Tringali A, Vanbiervliet G, Beyna T, Dinis-Ribeiro M, Hritz I, Mariani A, Paspatis G, Radaelli F, Lakhtakia S, Veitch AM, van Hooft JE. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2020 Feb;52(2):127-149. doi: 10.1055/a-1075-4080. Epub 2019 Dec 20.</citation>
    <PMID>31863440</PMID>
  </results_reference>
  <results_reference>
    <citation>Goldberg E, Titus M, Haluszka O, Darwin P. Pancreatic-duct stent placement facilitates difficult common bile duct cannulation. Gastrointest Endosc. 2005 Oct;62(4):592-6.</citation>
    <PMID>16185975</PMID>
  </results_reference>
  <results_reference>
    <citation>Devi√®re J. Why do pancreatic stents become occluded? Gastrointest Endosc. 2005 Jun;61(7):867-8.</citation>
    <PMID>15933689</PMID>
  </results_reference>
  <results_reference>
    <citation>Ikenberry SO, Sherman S, Hawes RH, Smith M, Lehman GA. The occlusion rate of pancreatic stents. Gastrointest Endosc. 1994 Sep-Oct;40(5):611-3.</citation>
    <PMID>7988829</PMID>
  </results_reference>
  <results_reference>
    <citation>Rashdan A, Fogel EL, McHenry L Jr, Sherman S, Temkit M, Lehman GA. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol. 2004 Apr;2(4):322-9.</citation>
    <PMID>15067627</PMID>
  </results_reference>
  <results_reference>
    <citation>Dultz G, Gerber L, Zeuzem S, Bojunga J, Friedrich-Rust M. Prolonged retention of prophylactic pancreatic stents is not associated with increased complications. Pancreatology. 2019 Jan;19(1):39-43. doi: 10.1016/j.pan.2018.11.011. Epub 2018 Nov 22.</citation>
    <PMID>30502123</PMID>
  </results_reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 28, 2020</study_first_submitted>
  <study_first_submitted_qc>December 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 31, 2020</study_first_posted>
  <last_update_submitted>January 3, 2021</last_update_submitted>
  <last_update_submitted_qc>January 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>DongGuk University</investigator_affiliation>
    <investigator_full_name>Dong Kee Jang</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Cholangitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

